Monday, October 21st, 2024

7:00a | Educational Conference | Dana 9

Journal Club: A discussion of TNT in rectal cancer. We will discuss the two articles below, attached to this post.

  • Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
  • Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy A Secondary Analysis of the OPRA Randomized Clinical Trial
Conference documents: 
AttachmentSize
PDF icon OPRA.pdf3.58 MB
PDF icon OPRA II.pdf1.07 MB